Health ProductsNotice to Hospitals

(Update) Plum A+ Infusion Pumps - Recall Due to Audible Alarm Failure - Notice to Hospitals

· Published by Health Canada · Official notice

Details

Alert type: Notice to Hospitals
Category: Medical Device
Audience: Healthcare Professionals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

This is duplicated text of a letter from Hospira Healthcare Corporation.
Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

Notice to Hospitals - Health Canada Endorsed Important Safety Information on Hospira Plum A+ Infusion Pumps (UPDATE)

March 7, 2011

Dear Healthcare Professional:

Please distribute to relevant Departments (Surgery, Emergency Medicine, Pharmacy, Paediatrics, Anaesthesia, Geriatrics, Internal Medicine, Nursing, Intensive Care and/or other Departments as required), and other involved professional staff and post this Notice in your institution.

Subject: UPDATE: Recall of all Plum A+ Infusion Pumps due to audible alarm failure

Recall of all Plum A+ Infusion Pumps due to audible alarm failure
Product List Number
Plum A+ Hyperbaric Infusion Pump 11005
Plum A+ Infusion Pump 12391
Plum A+3 Infusion Pump 12618
Plum A+3 with Hospira MedNet Software 20678
Plum A+ with Hospira MedNet Software 20679
Plum A+ Driver 20792

This is an update to our communication dated February 14, 2011. Following several inquiries received from customers regarding the test method recommended by Hospira in the previous communication, Hospira has validated an alternate method to perform the audible alarm test. This new method does not require the use of a dry cassette and may be used in place of the original test method described.

Note that this test will identify if the alarm has already failed.  However, even if a pump successfully passes this test, this does not guarantee that the alarm will not fail during the next clinical use.

To perform the test:

  1. Turn on the infuser.
  2. Insert primed set.
  3. Close door and let infuser initialize.
  4. After the infuser passes initialization and cassette test with no alarm, do the following:
    • Open door lever.
    • Pinch tubing proximally (2 to 4 inches above the cassette).
    • With the tubing still pinched, close door lever and the cassette test will take place again.
  5. Verify the N185 Proximal occlusion and audible alarm sounds.
    • If the audible alarm does sound, silence the alarm, open the door, remove the occlusion from the set, re-close the door and let the pump go through the cassette test again. Continue to use the device after the cassette test is complete.
    • If the audible alarm does not sound, remove the infuser from service and contact Hospira Canadian Service Center at 1-866-488-6088 Option 5.

Hospira personnel will provide additional training support as needed to ensure staff members have a clear understanding of the alarm test procedure.  Please contact your Hospira representative to request training support.

Hospira is developing a design improvement to resolve this issue. Validation of this solution for all device configurations is in progress. Once the redesign activities are complete and inventory is available, Hospira will notify customers to schedule replacement of the buzzer assemblies.

Please complete the attached Reply Form and return it via fax to the number on the form.

Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any cases of alarm failure or other serious or unexpected adverse incidents for medical devices in patients using Plum A+ Infusion Pumps should be reported to Hospira, Inc. or Health Canada at the following addresses:

Hospira Healthcare Corporation
1111 Dr. Frederik-Philips Blvd
Saint-Laurent, Quebec
H4M 2X6

Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.

For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738

To change your mailing address or fax number, contact the Market Authorization Holder (Industry).

Sincerely,

original signed by

Beryl Chan
Regional Director, Quality & Regulatory Affairs

This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.

Download PDF document

UPDATE TO FIELD CORRECTION Reply Form.

RESPONSE REQUIRED

No Audible Alarm (March 7, 2011)

PLUM A+™ Family of Infusers

COMPLETE THE INFORMATION AND FAX THE COMPLETED FORM TO 1-877-906-0208.

  1. We have received the two Customer Notification related to PLUM A+ (February 14 & March 7) and distributed it to users throughout the facility:
    • YES
    • NO
    • If NO, state reason:
  2. Following the review of the two proposed methods, We have elected to use:
  • The dry cassette test method
  • The proximal occlusion method

Customer Information

Business Name

Address/City/Province/Postal code

Hospira Customer Number (if applicable)

Contact Name

Contact Phone/e-mail Address

Completed by: Printed Name/Signature/Date

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime